Sermorelin
An educational overview of Sermorelin, a growth hormone-releasing hormone (GHRH) analog investigated for endogenous growth hormone release, endocrine physiology, IGF-1 biology, and body composition research.
Peptide Class
GHRH AnalogCategory
Growth HormonePrimary Target
GHRH ReceptorResearch Interest
HighResearch Snapshot
Overview
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Researchers investigate its ability to stimulate endogenous growth hormone release through activation of the GHRH receptor.
Published research explores its role in endocrine physiology, IGF-1 biology, body composition, recovery, and healthy aging.
How It Works
Sermorelin activates GHRH receptors within the pituitary gland, promoting physiologic growth hormone release. Scientists continue studying downstream effects on IGF-1 production and metabolic function.
Areas of Scientific Interest
Related Compounds
FAQ
Is Sermorelin growth hormone?
No. Sermorelin is a GHRH analog researched for stimulating the body's own growth hormone release.
What is its primary research target?
Its primary research target is the growth hormone-releasing hormone receptor (GHRH receptor).
Does this page include dosage information?
No. Cloud Peptides does not provide dosage recommendations or administration guidance.
Research Use Only
This page summarizes publicly available scientific literature for educational purposes only.
Cloud Peptides does not provide medical advice, treatment recommendations, or dosage information.
All products are intended strictly for laboratory research purposes only and are not for human consumption.